Center for Scientific Review; Notice of Closed Meetings
Published Date: 11/25/2025
Notice
Summary
The NIH’s Center for Scientific Review is holding a closed virtual meeting on December 10, 2025, to review important grant applications in immune oncology research. This meeting was delayed due to a government shutdown but is now urgent to keep vital health research funding on track. Scientists and researchers waiting on NIH grants are the ones affected, with no direct cost changes but a tight timeline to meet funding deadlines.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
NIH resumes urgent grant reviews
If you are a scientist or researcher with an NIH R21 immune oncology grant application, the NIH Center for Scientific Review will hold a closed virtual meeting on December 10, 2025, from 9:00 a.m. to 3:00 p.m. to review and evaluate applications. The meeting was delayed by a 43-day government shutdown and is being held urgently so evaluations can be submitted for timely funding recommendations; this does not change award amounts but affects the timing of decisions.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14980, Government Owned Invention Available for License: Pigment Epithelium-Derived Factor Peptides and Their Use for Treating Retinal Degeneration
The National Eye Institute has a cool new invention using special peptides to help protect eyes from inherited diseases like retinitis pigmentosa, which causes vision loss for over 100,000 Americans. They’re looking for partners to help develop easy-to-use eyedrops or gene therapy to slow down or stop this eye damage. This could bring hope and new treatments to many people with few options, and interested parties can start talking to the NIH now!
Previous / Next Documents
Previous: 2025-20936, Information Collection Being Reviewed by the Federal Communications Commission Under Delegated Authority
The FCC is checking in on a form businesses and governments use to report interference problems with emergency and enterprise services. They want your feedback by January 26, 2026, to make sure the form is useful, clear, and not too much work—especially for small businesses. This review won’t cost extra but helps keep things running smoothly and saves time for everyone involved.
Next: 2025-20938, Foreign-Trade Zone (FTZ) 81, Notification of Proposed Production Activity; SubCom, LLC; (Undersea Fiber-Optic Cables and Repeaters); Newington, New Hampshire
SubCom, LLC wants to make undersea fiber-optic cables and repeaters at its Newington, New Hampshire facility inside Foreign-Trade Zone 81. This means they can bring in certain parts from other countries with lower or no import taxes, helping them save money and boost production. The public can share their thoughts until January 5, 2026, before the government decides.